Aase and Ejnar Danielsens Foundation   Report issue

Foundation Phase 3 Phase 4
Founded: Lyngby Denmark (1975)

Organization Overview

First Clinical Trial
2006
NCT00328796
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now